SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Myseum, Inc. Common Stock (DATS) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 35/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DATS
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio20,258.94
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.62
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-1.75 |
$0.00 |
$-1.55M |
- |
| 2017 |
$-2.31 |
$0.00 |
$-2.5M |
- |
| 2018 |
$-2.03 |
$0.00 |
$-4.91M |
- |
| 2019 |
$-3.90 |
$0.00 |
$-6.73M |
- |
| 2020 |
$-0.60 |
$0.00 |
$-1.03M |
- |
| 2021 |
$-7.10 |
$4.45K |
$-10.83M |
-243622.8% |
| 2022 |
$-6.04 |
$46.21K |
$-12.14M |
-26266.9% |
| 2023 |
$-4.14 |
$672.00 |
$-8.41M |
-1250744% |
| 2024 |
$-1.43 |
$436.00 |
$-4.24M |
-972247.7% |
| 2025 |
$-0.62 |
$550.00 |
$-2.61M |
-474049.5% |
